Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L M Almond

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
International Journal of Surgery (London, England)|February 6, 2010
A 5-year prospective review of posterior partial fundoplication in the management of gastroesophageal reflux diseaseL M Almond, M S Wadley
The British Journal of Surgery|June 27, 2014
Meta-analysis of endoscopic therapy for low-grade dysplasia in Barrett's oesophagusL M Almond, J Hodson, H Barr
Clinical Oncology (Royal College of Radiologists (Great Britain))|March 24, 2017
An Update on Non-extremity Soft Tissue SarcomasS J Ford, L M Almond, A Gronchi
Frontline Gastroenterology|August 26, 2017
Barrett's oesophagus: how should we manage it?O J Old, L M Almond, H Barr
International Journal of Surgery (London, England)|October 28, 2009
Postcholecystectomy syndrome (PCS)S S Jaunoo, S Mohandas, L M Almond
British Journal of Neurosurgery|April 25, 2007
Thoracic intradural disc herniationL M Almond, N A Hamid, J Wasserberg
International Journal of Surgery (London, England)|September 20, 2014
Endoscopic resection with or without mucosal ablation of high grade dysplasia and early oesophageal adenocarcinoma--long term follow up from a regional UK centreZoe Oliphant, Alec Snow, Hannah Knight, et al.
British Journal of Hospital Medicine (London, England : 2005)|May 16, 2012
Current management of Barrett's oesophagusJ M L Williamson, L M Almond, N A Shepherd, et al.
Current Drug Metabolism|June 13, 2009
Towards a quantitative framework for the prediction of DDIs arising from cytochrome P450 inductionL M Almond, J Yang, M Jamei, et al.
Antimicrobial Agents and Chemotherapy|October 26, 2022
Physiologically Based Pharmacokinetic Modeling To Guide Management of Drug Interactions between Elexacaftor-Tezacaftor-Ivacaftor and Antibiotics for the Treatment of Nontuberculous MycobacteriaE Hong, L M Almond, P S Chung, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
International Journal of Surgery (London, England)|February 6, 2010
A 5-year prospective review of posterior partial fundoplication in the management of gastroesophageal reflux diseaseL M Almond, M S Wadley
The British Journal of Surgery|June 27, 2014
Meta-analysis of endoscopic therapy for low-grade dysplasia in Barrett's oesophagusL M Almond, J Hodson, H Barr
Clinical Oncology (Royal College of Radiologists (Great Britain))|March 24, 2017
An Update on Non-extremity Soft Tissue SarcomasS J Ford, L M Almond, A Gronchi
Frontline Gastroenterology|August 26, 2017
Barrett's oesophagus: how should we manage it?O J Old, L M Almond, H Barr
International Journal of Surgery (London, England)|October 28, 2009
Postcholecystectomy syndrome (PCS)S S Jaunoo, S Mohandas, L M Almond
British Journal of Neurosurgery|April 25, 2007
Thoracic intradural disc herniationL M Almond, N A Hamid, J Wasserberg
International Journal of Surgery (London, England)|September 20, 2014
Endoscopic resection with or without mucosal ablation of high grade dysplasia and early oesophageal adenocarcinoma--long term follow up from a regional UK centreZoe Oliphant, Alec Snow, Hannah Knight, et al.
British Journal of Hospital Medicine (London, England : 2005)|May 16, 2012
Current management of Barrett's oesophagusJ M L Williamson, L M Almond, N A Shepherd, et al.
Current Drug Metabolism|June 13, 2009
Towards a quantitative framework for the prediction of DDIs arising from cytochrome P450 inductionL M Almond, J Yang, M Jamei, et al.
Antimicrobial Agents and Chemotherapy|October 26, 2022
Physiologically Based Pharmacokinetic Modeling To Guide Management of Drug Interactions between Elexacaftor-Tezacaftor-Ivacaftor and Antibiotics for the Treatment of Nontuberculous MycobacteriaE Hong, L M Almond, P S Chung, et al.
Pageof 2